Study on MDMA for pain relief in healthy people
Treatments studied
This trial tests if a single dose of MDMA can reduce pain caused by heat or pressure in healthy volunteers. It aims to see if MDMA might help with certain types of pain that are hard to treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You understand German well enough to follow study instructions
- You are willing to not use any illegal drugs during the study
- You are willing to avoid driving or operating heavy machinery for 2 days after each session
- You have a body mass index (BMI) between 18 and 34.9
- You are generally healthy with no major medical or psychiatric conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how three different psychedelic substances affect your state of mind. The goal is to better understand these altered states, which may help develop future treatments.
This trial tests if MDMA, combined with psychotherapy, can help people with severe chronic nerve pain that hasn't improved with standard treatments. You'll receive either MDMA or a placebo to see if it safely reduces pain and improves your quality of life.
This trial tests if MDMA-assisted therapy can help mental healthcare providers. It involves taking MDMA in a therapeutic setting while being recorded, and you must be trained in this type of therapy.
This trial tests whether MDMA (a drug sometimes called 'ecstasy') can help people with fibromyalgia when used alongside therapy sessions. The goal is to see if it reduces pain and improves quality of life.
This Phase 2 study tests whether MDMA combined with structured therapy can reduce stress symptoms in people who have been exposed to major work-related stress in healthcare or emergency response. It’s designed to help participants during special “experimental” sessions plus regular therapy sessions without MDMA.
This early-phase study looks at whether MDMA is tolerable (safe enough) in people diagnosed with schizophrenia. Researchers will check safety while you stay stable on your usual care.
Hear when a new Healhty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.